Table 2. Immunoglobulin levels per CHARGE patient.
| Patient | Immunoglobulin levels 1 | |||||||
|---|---|---|---|---|---|---|---|---|
| IgG | IgA | IgM | IgG1 | IgG2 | IgG3 | IgG4 | IgE | |
| CHD01 | 9.8 (5.2–15.6) | 1.3 (0.54–3.6) | 1.6 (0.13–2.4) | 7.4 (3.7–12.8) | 2.0 (0.85–6.1) | 0.6 (0.13–1.63) | 0.5 (0.023–2.3) | 13 (<100) |
| CHD02 | 8.2 (5.2–15.6) | 1.1 (0.54–3.6) | 0.6 (0.13–2.4) | 6.3 (3.7–12.8) | 1.5 (0.85–6.1) | 0.3 (0.13–1.63) | 0.2 (0.023–2.3) | 29 (<50) |
| CHD04 | 9.2 (4.3–13.4) | 1.2 (0.19–2.2) | 1.3 (0.21–1.8) | 7.3 (3.2–12.8) | 1.5 (0.52–3.4) | 0.4 (0.13–1.33) | 0.2 (0.012–1.58) | 20 (<10) |
| CHD05 | 6.1 (5.2–15.6) | 0.5 (0.54–3.6) | 0.9 (0.13–2.4) | 5.4 (3.7–12.8) | 1.3 (0.85–6.1) | 0.3 (0.13–1.63) | 0.2 (0.023–2.3) | 84 (<100) |
| CHD06 | 8.0 (7.0–16.0) | 0.7 (0.70–4.0) | 0.9 (0.40–2.3) | 5.9 (3.7–12.8)) | 2.1 (0.85–6.1) | 0.7 (0.13–1.63) | 0.1 (0.023–2.3) | 420 (<100) |
| CHD08 | 10.1 (5.2–15.6) | 1.2 (0.54–3.6) | 0.6 (0.13–2.4) | 7.6 (3.7–12.8) | 1.8 (0.85–6.1) | 0.9 (0.13–1.63) | 1.3 (0.023–2.3) | 12 (<100) |
| CHD09 | 7.2 (4.3–13.4) | 0.4 (0.19–2.2) | 1.0 (0.21–1.8) | 6.0 (3.2–10.0) | 1.3 (0.52–3.4) | 0.2 (0.13–1.33) | 0.5 (0.012–1.58) | <2.0 (<10) |
| CHD10 | 7.0 (4.3–13.4) | 0.5 (0.19–2.2) | 1.1 (0.21–1.8) | 5.8 (3.2–10.0) | 1.6 (0.52–3.4) | 0.3(0.13–1.33) | 0.8 (0.012–1.58) | 15 (<10) |
| CHD11 | 9.9 (5.2–15.6) | 2.5 (0.54–3.6) | 0.7 (0.13–2.4) | 5.9 (3.7–12.8) | 3.5 (0.85–6.1) | 0.3 (0.13–1.63) | 0.5 (0.023–2.3) | 13 (<100) |
| CHD12 | 9.7 (4.3–13.4) | 1.2 (0.19–2.2) | 1.1 (0.21–1.8) | 5.6 (3.2–10.0) | 3.0 (0.52–3.4) | 0.4 (0.13–1.33) | 2.2 (0.012–1.58) | 145 (<50) |
| CHD13 | 6.8 (4.3–13.4) | 0.6 (0.19–2.2) | 0.7 (0.21–1.8) | 6.0 (3.2–10.0) | 0.8 (0.52–3.4) | 0.3 (0.13–1.33) | <0.1 (0.012–1.58) | 24 (<25) |
| CHD14 | 7.0 (5.2–15.6) | 1.2 (0.54–3.6) | 1.3 (0.13–2.4) | 5.4 (3.7–12.8) | 2.1 (0.85–6.1) | 0.3 (0.13–1.63) | 0.3 (0.023–2.3) | 7.5 (<25) |
| CHD15 | 12.3 (5.2–15.6) | 2.1 (0.54–3.6) | 1.2 (0.13–2.4) | 8.1 (3.7–12.8) | 3.4 (0.85–6.1) | 0.4 (0.13–1.63) | 3.0 (0.023–2.3) | 70 (<100) |
| CHD16 | 9.4 (5.2–15.6) | 1.1 (0.54–3.6) | 0.5 (0.13–2.4) | 7.0 (3.7–12.8) | 1.8 (0.85–6.1) | 0.3 (0.13–1.63) | 0.8 (0.023–2.3) | 22 (<100) |
| CHD17 | 11.2 (4.3–13.4) | 0.8 (0.19–2.2) | 1.0 (0.21–1.8) | 9.2 (3.7–12.8) | 1.2 (0.52–3.4) | 0.4 (0.13–1.33) | 0.3 (0.012–1.58) | 70 (<10) |
| CHD18 | 8.3 (2.6–15.2) | 0.7 (0.16–1.1) | 0.9 (0.10–1.2) | 7.3 (2.0–8.5) | 1.3 (0.34–2.6) | 0.5 (0.15–1.13) | <0.1 (0.011–0.79) | 2.9 (<10) |
| CHD19 | 12.8 (5.2–15.6) | 0.9 (0.54–3.6) | 1.5 (0.13–2.4) | 8.0 (3.7–12.8) | 3.1 (0.85–6.1) | 0.7 (0.13–1.63) | 0.2 (0.023–2.3) | 7.1 (<100) |
| CHD20 | 11.0 (5.2–15.6) | 1.1 (0.54–3.6) | 1.5 (0.13–2.4) | 9.2 (3.7–12.8) | 1.4 (0.85–6.1) | 0.5 (0.13–1.63) | 0.5 (0.023–2.3) | 27 (<50) |
| CHD21 | 11.4 (5.2–15.6) | 3.1 (0.54–3.6) | 1.8 (0.13–2.4) | 8.3 (3.7–12.8) | 3.0 (0.85–6.1) | 0.5 (0.13–1.63) | 2.0 (0.023–2.3) | 1231 (<100) |
| CHD22 | 6.1 (4.3–13.4) | 0.5 (0.19–2.2) | 0.9 (0.21–1.8) | 5.2 (3.2–10.0) | 1.2 (0.52–3.4) | 0.2 (0.13–1.33) | <0.1 (0.012–1.58) | 190 (<10) |
| CHD23 | 6.7 (5.2–15.6) | 1.3 (0.54–3.6) | 1.0 (0.13–2.4) | 5.6 (3.7–12.8) | 1.7 (0.85–6.1) | 0.3 (0.13–1.63) | <0.1 (0.023–2.3) | 26 (<50) |
| CHD25 | 12.0 (4.3–13.4) | 1.4 (0.19–2.2) | 0.8 (0.21–1.8) | 9.2 (3.2–10.0) | 1.3 (0.52–3.4) | 0.4 (0.13–1.33) | 0.4 (0.012–1.58) | 160 (<25) |
| CHD26 | 12.7 (5.2–15.6) | 2.3 (0.54–3.6) | 2.2 (0.13–2.4) | 10.6 (3.7–12.8) | 0.9 (0.85–6.1) | 0.5 (0.13–1.63) | 0.2 (0.023–2.3) | 56 (<100) |
| CHD27 | 13.3 (5.2–15.6) | 1.7 (0.54–3.6) | 2.3 (0.13–2.3) | 10.0 (3.7–12.8) | 3.3 (0.85–6.1) | 1.1 (0.13–1.63) | 1.0 (0.023–2.3) | 138 (<100) |
1 Immunoglobulin concentration in g/l, except for IgE (IE/ml). Age-matched reference values are shown in brackets [12]. Values below or above the age-matched reference values are shown in bold.